Status:
RECRUITING
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Lead Sponsor:
University of Colorado, Denver
Conditions:
Lumbar Spinal Stenosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Detailed Description
Recent evidence suggests the use of liposomal bupivicaine (LB) in lumbar spine surgery shortens length of hospital stay and overall post-operative narcotic use. Studies have shown its utility in singl...
Eligibility Criteria
Inclusion
- Male or Female
- Adult (≥18 yo)
- Lumbar stenosis
Exclusion
- Co-morbidities precluding surgery
- ≤18 yo
- Pregnant
- Breastfeeding
- Need for instrumented fusion
- Prisoners
- Intra-operative CSF leak (identified by gush of CSF)
- Daily pre-operative opioid use of \> 25 morphine Eq/day
- Previous lumbar surgery at indicated level
Key Trial Info
Start Date :
September 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04066296
Start Date
September 8 2019
End Date
January 1 2025
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045